CRSP: CRISPR Therapeutics AG Stock

by  •  • Comments Off on CRSP: CRISPR Therapeutics AG Stock

SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)

Valuation
Market Cap ($M) 4,325.61
Enterprise Value ($M) 4,027.35
Book Value ($M) 1,932.08
Book Value / Share 22.53
Price / Book 2.24
NCAV ($M) 1,627.18
NCAV / Share 18.97
Price / NCAV 2.66

Profitability (mra)
Return on Invested Capital (ROIC) -0.17
Return on Assets (ROA) -0.16
Return on Equity (ROE) -0.19

Liquidity (mrq)
Quick Ratio 22.07
Current Ratio 22.07

Balance Sheet (mrq) ($M)
Current Assets 1,937.13
Assets 2,242.03
Liabilities 309.95
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 37.31
Operating Income -466.57
Net Income -366.25
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -142.77
Cash from Investing -280.48
Cash from Financing 331.98

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
8 days ago 13G/A ARK Investment Management LLC
04-10 13G/A Capital International Investors 10.20 28.08
2024-02-12 13G/A Nikko Asset Management Americas, Inc. 4.24 -15.89
2024-02-05 13G/A Sumitomo Mitsui Trust Holdings, Inc. 4.24 -15.89

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-08 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-02-21 522,334 2,468,769 21.16
2025-02-20 530,951 2,789,158 19.04
2025-02-19 978,357 4,482,212 21.83
2025-02-18 1,260,452 5,504,520 22.90

(click for more detail)

Similar Companies
CMRX – Chimerix, Inc. CRMD – CorMedix Inc.
CRON – Cronos Group Inc. CRVS – Corvus Pharmaceuticals, Inc.
CURR – CURRENC Group Inc.


Financial data and stock pages provided by
Fintel.io